Welcome to LookChem.com Sign In|Join Free
  • or
trans-3-aminotetralin-2-ol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

132499-48-0

Post Buying Request

132499-48-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

132499-48-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 132499-48-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,4,9 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 132499-48:
(8*1)+(7*3)+(6*2)+(5*4)+(4*9)+(3*9)+(2*4)+(1*8)=140
140 % 10 = 0
So 132499-48-0 is a valid CAS Registry Number.

132499-48-0Downstream Products

132499-48-0Relevant academic research and scientific papers

Compounds with Bridgehead Nitrogen

Crabb, Trevor A.,Roch, Olive G.,Robinson, Paul

, p. 1069 - 1072 (1986)

In contrast to the reported reaction between trans-1-aminotetralin-2-ol and formaldehyde, which gives r-6a,c-9a,t-15a,t-18a-5,6,6a,9a,14,15,15a,18a-octahydro-9,18-methanodinaphthodioxadiazecine, an examination of the δ 4.0-5.0 region of the 1H NMR spectra of the products of the reaction between trans-3-aminotetralin-2-ol and formaldehyde showed these to be a 50:50 mixture of r-5a,t-8a,c-14a,t-17a- and r-5a,c-8a,t-14a,t-17a-5,5a,8a,9,14,14a,17a,18-octahydro-8,17-methanodinaphthodioxadiazecine.In a similar way, the reaction between trans-2-aminocyclohexanol and formaldehyde was reexamined and found to produce initially a ca 80:20 mixture of r-4a,t-7a,c-11a,t-14a- and r-4a,c-7a,t-11a,t-14a-7,14-methanoperhydrodibenzodioxadiazecines. KEY WORDS Octahydro-8,17-methanodinaphthodioxadiazecine 7,14-Methanoperhydrodibenze>1,6,3,8>dioxadiazecines 1H NMR Geminal coupling constants trans-3-Aminotetralin-2-ol

2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors

-

Page/Page column 26, (2010/11/08)

Novel compounds are provided which are glycogen phosphorylase inhibitors which are useful in treating, preventing or slowing the progression of diseases requiring glycogen phosphorylase inhibitor therapy such as diabetes and related conditions (such as hy

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 132499-48-0